Cost-effectiveness of 82-Rubidium PET myocardial perfusion imaging for the diagnosis of myocardial ischemia depending on the prevalence of coronary artery disease

EJNMMI Research

Original Research

Julie Bulsei¹  Meryl Darlington¹  Maroua Mimouni¹  Isabelle Durand-Zaleski²  François Rouzet³  Fabien Hyafil⁴  Candice Estellat⁵ 

[1] DRCI-URC Eco Ile-de-France, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France;DRCI-URC Eco Ile-de-France, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France;Service de Santé Publique, Henri Mondor-Albert-Chenevier, Assistance Publique-Hôpitaux de Paris, Créteil, France;UMR 1153 CRESS, INSERM, Paris, France;UPEC, Creteil, France;Department of Nuclear Medicine, Bichat Hospital, AP-HP, 75018, Paris, France;U-1148, INSERM, Paris, France;Université de Paris, 75018, Paris, France;Department of Nuclear Medicine, Georges-Pompidou European Hospital, DMU IMAGINA, AP-HP, University of Paris, 75015, Paris, France;U-970, INSERM, University of Paris, 75015, Paris, France;Département de Biostatistiques, Santé Publique et Informatique Médicale, Hôpital Pitié-Salpêtrière, AP-HP, 75013, Paris, France;CIC-EC 1425, ECEVE UMR 1123, INSERM, 75018, Paris, France;

关键词: Cost-effectiveness;    82-Rubidium PET;    SPECT;    Myocardial perfusion imaging;    Obstructive coronary artery disease;   

DOI  :  10.1186/s13550-023-00954-x

 received in 2022-11-16, accepted in 2023-01-15,  发布年份 2023

来源: Springer

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

13731_2023_266_Article_IEq2.gif

Fig. 5

Fig. 4